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Adenosine Receptors and Signaling in the Kidney 
W.S. Spielman~ L.J. Arend, K.-N. Klotz, and U. Schwabe 
~en adenosine binds to plasma-membrane receptors on a variety of cell 
types in the kidney, it stimulates functional responses that span the 
entire spectrum of renal cellular physiology, including alterations in 
hemodynamics, hormone and neurotransmi tter release, and tubular 
reabsorption (Table 1). This array of diverse responses, appears to 
represent a means by which the kidney and its constituent cell types can 
regulate the metabolic demand such that it is maintained at an 
appropriate level for the prevailing metabolic supply (Figure 1). With 
the increased recognition of this wide array of renal cellular actions, 
and the continuing development of relatively specific adenosine receptor 
agonist and antagonist ligands, investigators have undertaken the task 
of assigning the different renal actions of adenosine to the known 
adenosine receptor types, by comparison of relative agon1st and 
antagonist potencies. It is apparent from the inspection of a list of 
the renal actions of adenosine, that not on1y does adenosine control a 
variety of functions but it appears to have a "dual-control" over many 
aspects of renal function mediated by separate receptors. This approach, 
while providing useful information on the action and the possible 
receptor subtypes leaves some questions as to the coupling to secend 
messenger systems, and does not provide molecular information of the 
subcellular events that may be involved. 
With the exception of their ability to respond to adenosine and 
adenosine analogs, nothing as yet has been described that distinguishes 
adenosine receptors from the wide variety of receptors that modify 
adenylate cyclase activity and are therefore likely members of a large 
class of hormone receptors that, like the visual pigment rhodopsin, are 
coupled to their intracellular effector systems by guanine nucleotide 
binding proteins. In some systems, however, it has been impossible to 
correlate physiological responses to adenosine with changes in levels of 
cAMP, and therefore, it has been proposed that adenosine may be coupled 
to other signal transduction systems as well. In the kidney, several of 
the actions of adenosine associated with activation of the Al receptor 
(i. e. vasoconstriction, renin release inhibition, and inhibition of 
neurotransmitter release) are effects that have been proposed to be 
mediated by changes in cytosolic calcium (Churcbill and Churchill, 
1988). Wehave recently reported in primary cultures of rabbit cortical 
collecting tubule cells (Arend et al., 1988) andin an established cell 
derived from RCCT cells (Arend et al., 1989) that in addition to the 
classical Al and A2 receptors coup1ed to the the inhibition and 
stimulation of adenylate cyclase (Arend et al., 1987), adenosine 
stimulates the turnover of inositol phosphates and 
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Table 1. Renal actions of adenosine 
-----·----·----------~-------------------------------------------------Effect Receptor 
Hemodynamic ( GFR) 0 •••• 0 •• o 0 o 0 • o o 0 •• 0 • 0 •• 
vasoconstriction (preglomerular) Al 
vasodilation (postglomerular) A2 
HormonalfNeurotransm~tter .... o 000 •• •••o• 0 
Renin release 
Inhibition A1 
Stimulation A2 
Erythropoietin. 0 • 0 ••••••••••• 0 •• 0 0 •••••• 
Inhibition A1 
Stimulation A2 
Adrenergic Transmission 
Inhibition (presynaptic) A1 
Tubular .......... 0 •••••••••• 0 • 0 •••••••••• 
Collecting Tubule 
LpA A2 
Thick Ascending Limb 
TNA A1 
----~-----------------·---------~--------------------------------------
the elevation of cytosolic free calcium. Furthermore this response is 
coupled to a pertussis toxin substrate, presumably a G protein, and is 
inhibited by the highly selective Al antagonist, 8-cyclopentyl~l,3· 
dipropylxanthine (DPCPX). Thus, activation of the renal epithelial At 
receptor results in the simultaneaus acceleration of inositol phosphate 
production and the inhibition of adenylate cyclase. 
The presence of two different mechanisms associated with the adenosine 
A1 receptors raises several important questions. The first and most 
obvious is whether or not two classes of Al receptors exist. One 
possibility is that both the inhibition of adenylate cyclase and the 
acceleration of inositol polyphosphate production are provoked by a 
single receptor population via divergent coupling mechanisms. 
Alternatively, each response may be evoked by independent adenosine 
receptor populations indistinguishable in their specificity for 
currently available agon1st or antagonist ligands. Although GTP-binding 
proteins link receptor oceupancy to changes in both inhibition of 
cyelase and the acceleration of inositol phosphate production, the 
identity of the GTP-binding proteins involved in vivo and the mechanisms 
are not certain. Finally, is remains to be deteruained which of the 
possible signaling events induced by occupancy of receptors linked to 
the inhibition of adenylate cyclase andjor phospholipase C are causal in 
mediating a given physiological event~ which are permissive, and which 
are without any functional consequence in a given setting. 
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Figure 1. ADENOSINE FEEDBACK HYPOTHESIS 
FOR THE KIDNEY. Adenosine, presumably 
produced by transporting epithelium, 
acts to reduce GFR, via reduction of the 
glomerular hydrostatic pressure, by its 
vasoconstrictive action on the afferent 
arteriole and vasodilatory action on the 
efferent arteriole, and thereby, 
regulates the supply of delivered solute 
to the nephron. The action of adenosine 
to inhibit hormone-stimulated cyclic AMP 
in various segments of the nephron, both 
directly, and indirectly through the 
Inhibition of neurotransmitter release, 
serves to reduce the metabolic demand of 
the tubular cells. Together, these 
hemodynamic and tubular actions of 
adenosine work to return the metabolic 
supply and demand ratio toward a level 
of transport activity appropriate for 
the oxygen and substrate availability of 
the tissue. 
Radioligand Binding Analysis of Adenosine Al Receptors in 28A Cells. 
To determine whether or not a single population of Al receptors is 
coupled to these dive~ent signaling pathways, we have measured 
radioligand binding of [ H]DPCPX to plasma membranes from rabbit renal 
medulla and a cell line derived from the rabbit cortical collecting 
tubule (RCCT-28A). Saturation binding of [3H]DPCPX in 28A membranes 
(Figure 2) analyzed by non-linear curve fitting, gave a one-site model 
with an apparent Ko-value of 1.4 nM and a maximum nunber of binding 
sites (BMAX-value) of 64 fmol/mg protein. Scatchard analysis of the 
saturation curve gave a linear plot, indicating the presence of only one 
homogeneaus population of binding sites. The non-specific-binding was 
20-30% of the total at the Ko, and saturation of specific binding was 
reached with 2 nM [3H]DPCPX. 
Competition of several agonists for the [3H]DPCPX binding was measured 
to confirm that [ 3H] DPCPX binds to the Al receptor. Competition of 
adenosine agonists for [ 3H] DPCPX binding resulted in biphasic 
displacement curves (Table 2) indicating the presence of two affinity 
states for the agonists, with approximately one-half of the binding 
sites being in the high affinity state and the other half in the low 
affinity state. The Ki-values for the various adenosine receptor 
agonists exhibit the typical pharmacological profile for Al receptors 
and the marked stereoselectivity for the PIA enantiomers. 
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Figure 2. Saturation binding of [JH]DPCPX to RCT-28A cell membranes. 
Data are given as specific (closed circles) and non-specific binding 
(open circles). The inset shows the Scatchard plot from the data. 
Agonist bindin~ was further characterized by measuring the competition 
of R-PIA for [ H]DPCPX binding in the presence and absence of GTP (100 
uM). In the absence of GTP the competition of [ 3H]DPCPX by R-PIA 
resulted in a biphasic displacement curve with an apparent Ko-value of 
0. 5 nM and BMAX-value of 16.1 pmol/mg protein for the high affinity 
state and a low-affinity Ko-value of 10.5 nM and BMAX-value of 20.2 
fmol/mg protein. 
When the competition experiment was carried out in the presence of 100 
uM GTP, a monophasic curve was obtained, indicating a single affinity 
state with a K0 -value of 17.7 nM and a BMAX-value of 54.1 fmol/mg 
protein. Control binding (100%) increased from 36.3 to 54.1 fmol/mg 
protein with the addition of 100 uM GTP. 
These binding data confirm the previously reported functional data, that 
cells of the cortical collecting tubule have adenosine Al receptors 
coupled through GTP-binding proteins. Furthermore, these binding data 
fail to provide any support for the hypothesis that the inhibition of 
adenylate cyclase and the sti~ulation of phospholipase C are coupled to 
two sub-populations of the Al receptor, although it is recognized that 
this conclusion may be a function of the inability of currently 
available ligands to differentiate between the Al receptor subtypes. 
Table 2 
Pharmacological profile of (3H]DPCPX binding to RCCT-28A membranes. 
-------------------~--------------------------------------------------
Ki (nM) Ki (nM) 
CPPA 0.3 2.7 
R-PIA 0.5 7.0 
NECA 1.8 47 
S-PIA 3.1 275 
~-------------------------·-------------------------------------------
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Desensitization of the adenosine Al receptor: Differential effects on 
adegylate cyclase irihibition and pbospholipase C stimulation. 
Although the analysis of radioligand binding prov1ded no evidence in 
support of separate receptor sub-populations of the Al receptor 
mediating the divergent signaling mechanisms, it remained to be 
determined if activation of A1 receptors was invariably associated with 
both inhibition of adenylate cyclase and activation of phospholipase C, 
or alternatively, could the two signaling pathways be regulated 
separately, providing for more flexibility in control. 
Because prior exposure of cells to agon1st ligands is often associated 
with a desensitization of the response to subsequent addition of 
agonist, we sought to determine if it was possible to selectively 
desensitize either the A1 mediated decrease in adenylate cyclase 
activity or the Al mediated activation of phospholipase C. 
To determine if pretreatment of 28A cells with Al agonists produced a 
desensitization of mobilization of intracellular calcium to sebsequent 
addition of Al agonist, 28A cells were treated for 4 hr with increasing 
concentrations of CHA, an Al agonist, ranging from 10-8 to lo- 4 K. 
During the final hour of exposure to agonist, the cells were loaded with 
FURA-2, as previously described (Arend et al., 1988), for determination 
of cytosolic calcium concentration by spectrofluorometry. Cells were 
then thoroughly washed to remove the extracelluar FURA-2 and Al agonist. 
Without prior exposure to agonist, 1 uM CHA caused a 40% increase in the 
cytosolic calcium concentration. With prior exposure to agonist, this 
action of CHA to cause a stimulation of cytosolic calcium concentration 
is decreased in a concentration dependent manner. 
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Figure 3. Effect of pretreatment of 28A cells with CHA (4 hr) on CHA 
induced increase in cytosolic calcium. Values are means ± SEM of 10 
experiments. 
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Figure 4. Effect of increasing concentrations of CHA pretreatment (48 
hr) on CHA-induced Inhibition of cAMP production in 28A cells. 
To examine the ability of prior agon1st exposure to desensitize the Al 
Inhibition of adenylate cyclase activity, RCT-28A cells were pretreated 
for periods of 4, 12, 24, and 48 hr with vehicle or CHA at 
concentrations of 1, 10, and 100 nM. The cells were thoroughly washed 
and then reexposed to 50 nM CHA, the concentration at which we normally 
seemaximal inhibition of cAMP production (Arend et al., 1987) which is 
approximately 50% (Figure 4). When the cells were pre-exposed to CHA, no 
alteration in the ability of subsequent addition of 50 nM CHA on cAMP 
production was observed. 
In conclusion, in the absence of evidence of sub-populations of the Al 
receptor, it appears that activation of a single Al receptor population 
results in the inhibition of adenylate cyclase and the mobilization of 
cytosolic calcium. However, the finding that the divergent signaling 
mechanisms can be differentially regulated raises the possibility of 
separate control for the activation of phospholipase C and Inhibition of 
adenylate cyclase by adenosine. 
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